跳至主要内容
临床试验/NCT04789083
NCT04789083已完成不适用

The Effect of Propolis in Tinea Pedis Treatment: A Randomized Controlled Study

Necmettin Erbakan University2 个研究点 分布在 2 个国家目标入组 96 人开始时间: 2022年2月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
96
试验地点
2
主要终点
Evaluation

研究概览

简要总结

Tineapedis is an important health problem. Providing foot care in tinea pedis treatment contributes positively to the treatment. In addition, alternative treatments can also be used. In this study, the randomization study group will be divided into three. Medical treatment and foot care training will be applied to the first group, medical treatment and propolis to the second group, medical treatment and plassebo to the control group. Foot care training will be given by nurse coaching. Times of all three groups and their response to treatment will be evaluated.

详细描述

  1. Study Identification: Randomised Controlled Trial
  2. Study Status: This will begin
  3. Sponsor/Collaborators: SBS Scientific Bio Solutions Inc.
  4. Oversight: Patients will be given foot care training. At the same time, a phone call will be provided by the research nurse every week. Evaluation will be made at the end of 2 months
  5. Study Description

It was planned as a double-blind randomized controlled study. The person conducting the randomizer, the person making the statistics and the person performing the medical examiner will be blinded. Power analysis was made using the G * Power (3.1.9.4) program, 0.05 margin of error and 85% power were accepted. A total of 96 people were divided into three groups. Groups were composed of 36 people, including 10% losses for each group.

Inclusion Criteria:

Not being pregnant Not being breastfeeding Not having confusion Not being immunosuppressed Not using systemic cortisone Not having any dermatological problems (psoriasis, contact dermatitis, etc.) that will affect the treatment.

Agree to participate in research Being accessible by phone Having no problems communicating by phone Not having problems with physical care

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Not being pregnant
  • Not being breastfeeding
  • Not having confusion
  • Not being immunosuppressed
  • Not using systemic cortisone
  • Not having any dermatological problems (psoriasis, contact dermatitis, etc.) that will affect the treatment.
  • Agree to participate in research
  • Being accessible by phone
  • Having no problems communicating by phone
  • Not having problems with physical care

排除标准

  • Pregnant / nursing women
  • Using systemic antifungal therapy
  • Using systemic croticosteroids
  • In the process of treatment for oncological reasons
  • Are using immunosuppressants
  • Dermatological disease (contact dermatitis, psoriasis)
  • Under the age of 18 and over the age of 64
  • Have cognitive problems
  • There is no telephone / telephone number within reach
  • Individuals who have difficulties in speaking and understanding Turkish will be excluded from the study.

结局指标

主要结局

Evaluation

时间窗: 3 month

Dermatological Quality of Life Scale

次要结局

  • Doctor's an patient's global(3 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rukiye Burucu

Assit. Prof.

Necmettin Erbakan University

研究点 (2)

Loading locations...

相似试验